Trade tensions are impeding the flow of Chinese money to US biotechs — but how much?
US biotechs have seen a drastic drop in Chinese venture funding for the industry amid macro level trade tensions between the two countries and the American government’s heightened scrutiny of foreign investment. While VCs from China accounted for $1.65 billion worth of funding in the first half of last year, that figure has fallen nearly 60% to $725 million in 2019, the Financial Times reported citing PitchBook data.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
